Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation?
International Journal of Surgery Sep 12, 2017
Zhang X, et al. - Authors here determined the outcomes of salvage liver transplantation (SLT) and re-resection (RR)/radiofrequency ablation (RFA) with respect to the time to recurrence after initial curative resection of hepatocellular carcinoma. On the basis of findings, researchers recommended preferring SLT, rather than re-resection or RFA, as treatment option for patients with late recurrence.
Methods
- From 2007 and 2016, curative hepatectomy was performed on 756 patients for HCC in accordance with the Milan criteria.
- Among them, intrahepatic recurrence appeared in 152 patients; 36 underwent SLT and 116 underwent RR/RFA.
- The 2 groups were statistically compared regarding clinical data, overall survival (OS), and disease-free survival (DFS) (including subgroup analyses) according to the time to recurrence, and identification of prognostic factors was performed.
Results
- Much better DFS of the patients who underwent SLT was observed in comparison to patients who underwent RR/RFA (P = 0.002), particularly those with late recurrence (more than 12 months, P = 0.004).
- Findings suggested time to recurrence from initial hepatectomy as an independent predictor of OS and DFS.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries